These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 12575491)
1. Clinical applications of pharmaco-EEG in psychiatry: the prediction of response to treatment with antipsychotics. Galderisi S Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():85-9. PubMed ID: 12575491 [TBL] [Abstract][Full Text] [Related]
2. Predictive value of pharmaco-electroencephalography in early human-pharmacological evaluations of psychoactive drugs. First example: savoxepine. Herrmann WM; Schärer E; Delini-Stula A Pharmacopsychiatry; 1991 Nov; 24(6):196-205. PubMed ID: 1687485 [TBL] [Abstract][Full Text] [Related]
3. Pharmaco-EEG profile of maroxepine: third example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs. Herrmann WM; Schärer E; Wendt G; Delini-Stula A Pharmacopsychiatry; 1991 Nov; 24(6):214-24. PubMed ID: 1812498 [TBL] [Abstract][Full Text] [Related]
7. [Value of quantitative electroencephalography in psychiatry]. Etevenon P; Péron-Magnan P Sem Hop; 1982 Dec; 58(44):2606-14. PubMed ID: 6297054 [TBL] [Abstract][Full Text] [Related]
8. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals]. Bret P; Bret MC; Queuille E Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381 [TBL] [Abstract][Full Text] [Related]
9. Pharmaco-EEG profile of levoprotiline: second example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs. Herrmann WM; Schärer E; Wendt G; Delini-Stula A Pharmacopsychiatry; 1991 Nov; 24(6):206-13. PubMed ID: 1812497 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care. Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216 [TBL] [Abstract][Full Text] [Related]
11. Clozapine-induced QEEG changes correlate with clinical response in schizophrenic patients: a prospective, longitudinal study. Gross A; Joutsiniemi SL; Rimon R; Appelberg B Pharmacopsychiatry; 2004 May; 37(3):119-22. PubMed ID: 15138895 [TBL] [Abstract][Full Text] [Related]
12. Prescribing for inpatients with schizophrenia: an international multi-center comparative study. Bitter I; Chou JC; Ungvari GS; Tang WK; Xiang Z; Iwanami A; Gaszner P Pharmacopsychiatry; 2003 Jul; 36(4):143-9. PubMed ID: 12905100 [TBL] [Abstract][Full Text] [Related]
13. Substance abuse and the management of medication nonadherence in schizophrenia. Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865 [TBL] [Abstract][Full Text] [Related]
14. Planning of pharmacodynamic trials: I. Specificity and possible solutions. II. Stability considerations under placebo and interpretation of drug effects on EEG. Boeijinga PH; Calvi-Gries F; Demazières A; Luthringer R Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():17-26. PubMed ID: 12575484 [TBL] [Abstract][Full Text] [Related]
15. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. Kane JM; Leucht S; Carpenter D; Docherty JP; J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142 [TBL] [Abstract][Full Text] [Related]
16. Classification and evaluation of the pharmacodynamics of psychotropic drugs by single-lead pharmaco-EEG, EEG mapping and tomography (LORETA). Saletu B; Anderer P; Saletu-Zyhlarz GM; Arnold O; Pascual-Marqui RD Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():97-120. PubMed ID: 12575493 [TBL] [Abstract][Full Text] [Related]
17. Polypharmacy in psychiatry: a multi-state comparison of psychotropic drug combinations. Sheppard C; Beyel V; Fracchia J; Merlis S Dis Nerv Syst; 1974 Apr; 35(4):183-9. PubMed ID: 17894114 [TBL] [Abstract][Full Text] [Related]
18. Atypical and typical neuroleptics in acute schizophrenia and related delusional disorders. Drug choice, switching and outcome under naturalistic treatment conditions. Gaebel W; Riesbeck M; Janssen B; Schneider F; Held T; Mecklenburg H; Sass H Eur Arch Psychiatry Clin Neurosci; 2003 Aug; 253(4):175-84. PubMed ID: 12910348 [TBL] [Abstract][Full Text] [Related]
19. [Psychopathology of schizophrenia and brain imaging]. Gross G; Huber G Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545 [TBL] [Abstract][Full Text] [Related]
20. Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits. Chouinard S; Stip E; Poulin J; Melun JP; Godbout R; Guillem F; Cohen H Curr Med Res Opin; 2007 Mar; 23(3):575-83. PubMed ID: 17355738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]